Hata Yujiro S 4
4 · IDEAYA Biosciences, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Hata Yujiro S
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$19.52/sh+12,808$250,012→ 690,695 total - Exercise/Conversion
Stock Option (right to buy)
2025-02-18−12,808→ 182,192 totalExercise: $19.52Exp: 2031-02-23→ Common Stock (12,808 underlying)
Footnotes (1)
- [F1]The shares subject to the option are fully vested and exercisable.